Get started
Author

Yainyrette Rivera-Rivera

Observed names: Rivera-Rivera, Yainyrette, Yainyrette Rivera Rivera
Observed institution: Ponce Health Sciences University
OpenAlex ID: A5043669990
Impact of Depression and Inflammation on the Progression of HIV Disease
2016 · Yainyrette Rivera Rivera, Fabian J Vazquez Santiago · Journal of Clinical & Cellular Immunology · 85
The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells
2021 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Scientific Reports · 43
PDF
Centrosome – a promising anti-cancer target
2016 · Yainyrette Rivera-Rivera, Harold Saavedra · Biologics · 37
PDF
E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer
2021 · Shirley Jusino, Yainyrette Rivera-Rivera, et al. · Experimental Biology and Medicine · 31
The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1
2017 · Miyoung Lee, Yainyrette Rivera-Rivera, et al. · Oncotarget · 27
PDF
Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancers
2021 · Stephanie Colón-Marrero, Shirley Jusino, et al. · Experimental Biology and Medicine · 17
Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells
2020 · Meenu Maan, Neha Jaiswal Agrawal, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 17
PDF
Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers
2022 · Yainyrette Rivera-Rivera, Geraldine Vargas, et al. · Cell Division · 9
PDF
Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer
2023 · Shirley Jusino, Yainyrette Rivera-Rivera, et al. · Cell Division · 7
PDF
Shugoshin as a key mediator in the metastasis of triple negative breast cancer.
2023 · Valeria Julia Hernandez, Shirley Jusino, et al. · Journal of Clinical Oncology · 1
Shugoshin‐1 Depletion Reduces Tumor Growth in Triple‐Negative Breast Cancer
2022 · Patricia C. Rodríguez Rodríguez, Shirley Jusino, et al. · The FASEB Journal
Abstract 2545: Nek2 and other mitotic kinases are downstream of the E2F activators, and may modulate the epithelial-to-mesenchymal transition in breast cancer
2019 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Molecular and Cellular Biology / Genetics
Abstract 2545: Nek2 and other mitotic kinases are downstream of the E2F activators, and may modulate the epithelial-to-mesenchymal transition in breast cancer
2019 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Cancer Research
Abstract 1461: Targeting mitotic kinases in breast cancers in Latinas
2018 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Cancer Research
Abstract 3461: The Nek2 mitotic kinase drives centrosome amplification, mitotic dysfunction, and invasion in mammary epithelial and breast cancer cells
2017 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Cancer Research
Abstract C29: Addressing how the Nek2 mitotic kinase facilitates the epithelial to mesenchymal transition in breast cancer
2017 · Yainyrette Rivera-Rivera, Mihaela Marina, et al. · Cancer Epidemiology Biomarkers & Prevention
Works count: 20
Citation count: 274
H-index: 8
I10-index: 7
Year
Topic
Type